#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired ATTR amyloidosis Anaemia Congenital absence of bile ducts Follicle centre lymphoma follicular grade I, II – III Intracranial germ cell tumour Cluster headache Neuroendocrine tumour Cystic fibrosis Transient ischaemic attack Chronic graft versus host disease Type IIa hyperlipidaemia Hereditary ataxia Encephalitis autoimmune Glioblastoma Oesophageal squamous cell carcinoma stage III More trials…

    Learn about Rare Diseases

    Amyotrophic lateral sclerosis – Trials in Disease Waldenstrom’s macroglobulinaemia – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Basic Information Rhabdomyosarcoma – Diagnostics Hepatoblastoma – Treatment Andersen-Tawil syndrome Lymphatic malformation – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Lymphatic malformation Progressive multifocal leukoencephalopathy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Envudeucitinib Mk-1167 Lactose ANX007 Apocynin Human Normal Immunoglobulin Zanamivir Rucaparib Ucp4 Tolinapant Lactate Ropeginterferon Alfa-2B VG801-1 RO7268489 Gs-5245 2,4 DICHLOROBENZYL ALCOHOL Ziltivekimab Riluzole Rapcabtagene Autoleucel Protrans Fenebrutinib More therapies…

    Learn about Your Condition

    Ulcerative keratitis Neuroblastoma recurrent Magnetic resonance imaging Pouchitis Neuropathy peripheral Aortic valve disease Pulmonary hypertension Hypothyroidism Haematological malignancy Uterine leiomyosarcoma Chondrosarcoma metastatic Cholestatic pruritus Ischaemic skin ulcer Foetal growth restriction Penile cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study of LTX-315 and Pembrolizumab for Patients with Resectable Stage III-IV Melanoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Malignant melanoma stage III
    Investigated Drugs:
    • Ruxotemitide
    Norway

  • Study Comparing Effects of Ointments with Clotrimazole and Betamethasone Dipropionate for Patients with Moderate to Severe Skin Yeast Infections

    Recruiting

    3 1 1
    Investigated Diseases:
    • Skin candida
    Investigated Drugs:
    • Betamethasone Dipropionate
    • Clotrimazole
    Germany

  • Study on the Effectiveness of Carboplatin, Paclitaxel, and Pembrolizumab for Patients with Advanced Penile Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Penile cancer
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    • Pembrolizumab
    Belgium The Netherlands

  • Study on Treating Calcinosis Cutis in Systemic Sclerosis Patients with Sodium Thiosulfate, Cetrimide, and Lidocaine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Cetrimide
    • Lidocaine
    • Sodium Thiosulfate
    Denmark

  • Study on the Use of Plasma Rich in Growth Factors for Treating Foot Ulcers in Diabetic Patients with Peripheral Arterial Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • Platelet Concentrate
    Spain

  • Study Comparing Methylprednisolone Aceponate Creams and a Non-Active Cream for Patients with Mild to Moderate Atopic Dermatitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Methylprednisolone Aceponate
    Germany
Previous Page
1 … 15 16 17 18 19 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!